Stocks TelegraphStocks Telegraph
Stock Ideas

CLDI Company Profile and Key Details

AMEX : CLDI

Calidi Biotherapeutics, Inc.

$1.40
0.0801+6.07%
Open: 2:08 PM

CLDI Stock Price Chart

Stock Price Today

Calidi Biotherapeutics, Inc. (CLDI) stock surged +6.07%, trading at $1.40 on AMEX, up from the previous close of $1.32. The stock opened at $1.39, fluctuating between $1.20 and $1.50 in the recent session.

Stock Snapshot

1.32
Prev. Close
1.39
Open
36.28M
Market Cap
25.92M
Number of Shares
1.2
Day Low
1.5
Day High
-1.07
P/E Ratio
89.55%
Free Float in %
-1.31
EPS (TTM)
N/A
Book Value
N/A
Cash Flow per Share
3.53M
Volume

Stock Price History Chart

DateOpenHighLowCloseVolume
Feb 04, 20251.061.420.941.329.49M
Feb 03, 20250.751.140.721.059M
Jan 31, 20250.620.840.600.767.23M
Jan 30, 20250.640.650.580.63878.32K
Jan 29, 20250.630.670.600.64966.02K
Jan 28, 20250.660.690.620.66501.21K
Jan 27, 20250.720.720.650.66603.7K
Jan 24, 20250.760.780.730.74372.4K
Jan 23, 20250.770.780.720.76319.13K
Jan 22, 20250.830.840.680.761.93M
Jan 21, 20250.900.900.810.83523.6K
Jan 17, 20250.930.940.880.89299.02K
Jan 16, 20250.920.920.860.90600.38K
Jan 15, 20250.890.930.830.922.29M
Jan 14, 20250.950.950.850.89582.9K
Jan 13, 20250.930.940.840.92770.44K
Jan 10, 20250.950.970.820.922.94M
Jan 08, 20251.451.491.301.352.08M
Jan 07, 20251.291.491.261.472.38M
Jan 06, 20251.231.331.181.251.46M

Contact Details

San Diego, CA 92121

United States

Website: https://calidibio.comContact: 858 794 9600

About Company

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is based in San Diego, California.

Company Information

Employees41
Beta0.57
Sales or RevenueN/A
5Y Sales Change%0%
Fiscal Year EndsN/A
SectorHealthcare
IndustryBiotechnology

Frequently Asked Questions

What is the current Calidi Biotherapeutics, Inc. (CLDI) stock price?

Calidi Biotherapeutics, Inc. (AMEX: CLDI) stock price is $1.40 in the last trading session. During the trading session, CLDI stock reached the peak price of $1.50 while $1.20 was the lowest point it dropped to. The percentage change in CLDI stock occurred in the recent session was 6.07% while the dollar amount for the price change in CLDI stock was $0.08.

CLDI's industry and sector of operation?

The AMEX listed CLDI is part of Biotechnology industry that operates in the broader Healthcare sector. Calidi Biotherapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of CLDI?

No Data

How CLDI did perform over past 52-week?

CLDI's closing price is 127.59% higher than its 52-week low of $0.58 where as its distance from 52-week high of $16.80 is -92.14%.

How many employees does CLDI have?

Number of CLDI employees currently stands at 41.

Link for CLDI official website?

Official Website of CLDI is: https://calidibio.com

How do I contact CLDI?

CLDI could be contacted at phone 858 794 9600 and can also be accessed through its website. CLDI operates from 4475 Executive Drive, San Diego, CA 92121, United States.

How many shares of CLDI are traded daily?

CLDI stock volume for the day was 3.53M shares. The average number of CLDI shares traded daily for last 3 months was 2M.

What is the market cap of CLDI currently?

The market value of CLDI currently stands at $36.28M with its latest stock price at $1.40 and 25.92M of its shares outstanding.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph